Received Nov 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (AFLURIA) | SEQIRUS, INC. | 1 | AX5588A | IM / LA |
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 944906 | IM / RA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 1 | Y1D49P1 | IM / RA |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | 3 | U8638AA | IM / LA |
Patient was sitting in chair to receive vaccines. RN first administered Flu and Tdap in the left arm; patient tolerated well. RN then administered Hepatitis B and Polio in the right arm; patient appeared uneasy. RN asked patient if she would like some water and patient agreed. RN went to get water for patient and patient was talking to her sister in law. Patient's sister in law then said, "I think she fainted." RN walked back into room to see patient sitting in chair with head back and unresponsive; respirations were visible and palpated pulse was strong. RN used ammonia inhalant to wake patient; patient awakened initially confused; but quickly became AAOx4. Patient was cold and clammy. RN checked BP 117/90 and HR 81. SaO2 97%. Brought patient ice pack for forehead and apple juice. Patient finished apple juice and stated that she was feeling much better. Patient continued talking to RN and her sister in law. Proceeded with patient's blood draw which patient tolerated well. Patient stayed for an additional 30 minutes from vaccine administration with no other symptoms noted or reported. Discussed follow up with ER if difficulty breathing, hives, or additional syncope; discussed following up with PCP if needed.
Patient reported none.
Patient reported none.
Patient reported none.
Patient reported none.
Patient was in clinic to receive vaccines and lab work related to travel.